SINOVAC Initiates Clinical Trial for Its Quadrivalent Influenza Vaccine in Chile
Business Wire India Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that a phase III clinical trial for SINOVAC’s inactivated…